Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Zalcman · SciRah

Researcher profile · Semantic Scholar

G. Zalcman

Share profile

G. Zalcman — researcher profile on SciRah

h-index: 60
Works: 354
Citations: 26K

Most-cited papers

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial.
P. Baas, A. Scherpereel, A. Nowak, Nobukazu Fujimoto +17 more
2021The Lancet920 citations Open access
Semantic Scholar
Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer.
Y. Kieffer, H. Hocine, Géraldine Gentric, Floriane Pelon +12 more
2020Cancer Discovery741 citations
Semantic Scholar
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in advanced non-small cell lung cancer patients
L. Derosa, B. Routy, A. M. Thomas, V. Iebba +39 more
2022Nature Medicine591 citations Open access
Semantic Scholar
Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial.
C. Le Péchoux, N. Pourel, F. Barlesi, D. Lerouge +24 more
2021The Lancet Oncology226 citations
Semantic Scholar
Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial.
D. Moro-Sibilot, N. Cozic, M. Pérol, J. Mazières +20 more
2019Annals of Oncology188 citations Open access
Semantic Scholar
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)
A. Lièvre, A. Turpin, I. Ray-Coquard, K. Le Malicot +24 more
2020European Journal of Cancer140 citations Open access
Semantic Scholar
Non-small-cell lung cancer immunotherapy efficacy and antibiotic use: a systematic review and meta-analysis.
L. Lurienne, Julie Cervesi, L. Duhalde, J. de Gunzburg +4 more
2020Journal of Thoracic Oncology130 citations Open access
Semantic Scholar
LBA3_PR An international randomized trial, comparing post-operative conformal radiotherapy (PORT) to no PORT, in patients with completely resected non-small cell lung cancer (NSCLC) and mediastinal N2 involvement: Primary end-point analysis of LungART (IFCT-0503, UK NCRI, SAKK) NCT00410683
C. Le Péchoux, N. Pourel, F. Barlesi, C. Faivre-Finn +16 more
202090 citations Open access
Semantic Scholar
Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO)
M. Wislez, J. Mazières, A. Lavolé, G. Zalcman +16 more
2022Journal for ImmunoTherapy of Cancer85 citations Open access
Semantic Scholar
Randomized Open-Label Controlled Study of Cancer Vaccine OSE2101 Versus Chemotherapy in HLA-A2-positive Patients with Advanced Non-Small Cell Lung Cancer with Resistance to Immunotherapy: ATALANTE-1.
B. Besse, E. Felip, R. Campelo, M. Cobo +64 more
2023Annals of Oncology76 citations Open access
Semantic Scholar
Combination of Trastuzumab, Pertuzumab, and Docetaxel in Patients With Advanced Non–Small-Cell Lung Cancer Harboring HER2 Mutations: Results From the IFCT-1703 R2D2 Trial
J. Mazières, C. Lafitte, C. Ricordel, L. Greillier +15 more
2022Journal of Clinical Oncology68 citations
Semantic Scholar
A systematic review and meta-analysis evaluating the impact of antibiotic use on the clinical outcomes of cancer patients treated with immune checkpoint inhibitors
A. Crespin, C. Le Bescop, J. de Gunzburg, F. Vitry +3 more
2023Frontiers in Oncology66 citations Open access
Semantic Scholar
Unmet needs in clinical nutrition in oncology: a multinational analysis of real-world evidence
R. Caccialanza, F. Goldwasser, O. Marschal, F. Ottery +4 more
2020Therapeutic Advances in Medical Oncology64 citations Open access
Semantic Scholar
Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous non-small-cell lung cancer: Results of the IFCT-1103 ULTIMATE study.
A. Cortot, C. Audigier-Valette, O. Molinier, S. Le Moulec +18 more
2020European Journal of Cancer64 citations Open access
Semantic Scholar
Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort.
S. Brosseau, C. Danel, A. Scherpereel, J. Mazières +16 more
2019Clinical Lung Cancer60 citations Open access
Semantic Scholar
Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics.
L. Mezquita, I. Preeshagul, É. Auclin, D. Saravia +33 more
2021European Journal of Cancer57 citations Open access
Semantic Scholar
Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses
V. Gounant, V. Ferré, G. Soussi, C. Charpentier +11 more
2021Journal of Thoracic Oncology56 citations Open access
Semantic Scholar
Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations.
M. Riudavets, E. Auclin, M. Mosteiro, N. Dempsey +34 more
2022European Journal of Cancer55 citations Open access
Semantic Scholar
Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial.
V. Westeel, P. Foucher, A. Scherpereel, J. Domas +32 more
2022The Lancet Oncology52 citations Open access
Semantic Scholar
Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article
J. Barrière, M. Carles, C. Audigier-Valette, D. Re +5 more
2021European Journal of Cancer49 citations Open access
Semantic Scholar
Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid Morphology
J. Cros, N. Theou-Anton, V. Gounant, R. Nicolle +16 more
2020Neuroendocrinology48 citations
Semantic Scholar
STK38 kinase acts as XPO1 gatekeeper regulating the nuclear export of autophagy proteins and other cargoes
A. Martin, M. Jacquemyn, J. Lipecka, C. Chhuon +12 more
2019EMBO Reports48 citations Open access
Semantic Scholar
ID:2908 First-Line Nivolumab + Ipilimumab vs Chemotherapy in Unresectable Malignant Pleural Mesothelioma: CheckMate 743
P. Baas, A. Scherpereel, A. Nowak, N. Fujimoto +16 more
202044 citations Open access
Semantic Scholar
In vitro bone metastasis dwelling in a 3D bioengineered niche.
Wei-Jing Han, R. El Botty, E. Montaudon, L. Malaquin +14 more
2020Biomaterials41 citations Open access
Semantic Scholar
Efficacy of lorlatinib in treatment-naive patients with ALK-positive advanced non-small cell lung cancer in relation to EML4::ALK variant type and ALK with or without TP53 mutations.
A. Bearz, J. Martini, J. Jassem, Sang-We Kim +11 more
2023Journal of Thoracic Oncology39 citations Open access
Semantic Scholar
Antiangiogeneic Strategies in Mesothelioma
A. Nowak, S. Brosseau, A. Cook, G. Zalcman
2020Frontiers in Oncology37 citations Open access
Semantic Scholar
Direct imaging and automatic analysis in tumor-on-chip reveal cooperative antitumoral activity of immune cells and oncolytic vaccinia virus.
A. Mencattini, C. Lansche, I. Veith, P. Erbs +8 more
2022Biosensors & bioelectronics33 citations Open access
Semantic Scholar
Comparison of Fast-Progression, Hyperprogressive Disease, and Early Deaths in Advanced Non-Small-Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or Chemotherapy.
R. Ferrara, L. Mezquita, M. Texier, J. Lahmar +25 more
2020JCO Precision Oncology32 citations Open access
Semantic Scholar
IND227 phase III (P3) study of cisplatin/pemetrexed (CP) with or without pembrolizumab (pembro) in patients (pts) with malignant pleural mesothelioma (PM): A CCTG, NCIN, and IFCT trial.
Q. Chu, M. Piccirillo, L. Greillier, F. Grosso +16 more
2023Journal of Clinical Oncology30 citations Open access
Semantic Scholar
Biomarkers of Response to Etoposide-Platinum Chemotherapy in Patients with Grade 3 Neuroendocrine Neoplasms
C. Lacombe, O. De Rycke, A. Couvelard, A. Turpin +7 more
2021Cancers29 citations Open access
Semantic Scholar
First-line nivolumab plus ipilimumab versus chemotherapy for the treatment of unresectable malignant pleural mesothelioma: patient-reported outcomes in CheckMate 743.
A. Scherpereel, S. Antonia, Y. Bautista, F. Grossi +15 more
2022Lung Cancer28 citations Open access
Semantic Scholar
Grade 3–4 Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer (NSCLC) Patients Are Correlated with Better Outcome: A Real-Life Observational Study
N. Guezour, G. Soussi, S. Brosseau, B. Abbar +9 more
2022Cancers26 citations Open access
Semantic Scholar
NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells
M. Keller, F. Dubois, S. Teulier, A. Martin +9 more
2019Journal of experimental & clinical cancer research : CR26 citations Open access
Semantic Scholar
Treatment strategies and safety of rechallenge in the setting of immune checkpoint inhibitors-related myositis: A national multicenter study.
A. Weill, J. Delyon, V. Descamps, L. Deschamps +24 more
2021Rheumatology22 citations
Semantic Scholar
Intracranial efficacy of sotorasib versus docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC): Practice-informing data from a global, phase 3, randomized, controlled trial (RCT).
A. Dingemans, K. Syrigos, L. Livi, A. Paulus +16 more
2023Journal of Clinical Oncology20 citations Open access
Semantic Scholar
The STK38–XPO1 axis, a new actor in physiology and cancer
A. Martin, V. Aushev, G. Zalcman, J. Camonis
2020Cellular and Molecular Life Sciences18 citations
Semantic Scholar
Randomized Phase II Trial Evaluating Treatment with EGFR-TKI Associated with Antiestrogen in Women with Nonsquamous Advanced-Stage NSCLC: IFCT-1003 LADIE Trial
J. Mazières, F. Barlesi, I. Rouquette, O. Molinier +19 more
2020Clinical Cancer Research18 citations
Semantic Scholar
Definitions, outcomes, and management of hyperprogression in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors.
B. Abbar, V. de Castelbajac, P. Gougis, S. Assoun +10 more
2020Lung Cancer18 citations Open access
Semantic Scholar
NKX2.1 (TTF1) germline mutation associated with pulmonary fibrosis and lung cancer
R. Borie, B. Funalot, R. Epaud, C. Delestrain +6 more
2021ERJ Open Research17 citations Open access
Semantic Scholar
Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients
V. Gounant, M. Duruisseaux, G. Soussi, S. Van-Hulst +13 more
2021Cancers17 citations Open access
Semantic Scholar
Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study
R. Borie, L. Savale, A. Dossier, J. Ghosn +30 more
2020PLoS ONE17 citations Open access
Semantic Scholar
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti–PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma
F. Danlos, M. Texier, B. Job, S. Mouraud +39 more
2023Cancer Discovery16 citations Open access
Semantic Scholar
Intergroupe francophone de cancérologie thoracique, Société de pneumologie de langue française, and Société d'imagerie thoracique statement paper on lung cancer screening.
S. Couraud, G. Ferretti, B. Milleron, A. Cortot +11 more
2021Diagnostic and Interventional Imaging16 citations Open access
Semantic Scholar
[Recommendations of French specialists on screening for lung cancer].
S. Couraud, G. Ferretti, B. Milleron, A. Cortot +11 more
2021Revue des maladies respiratoires16 citations
Semantic Scholar
Proposals for managing patients with thoracic malignancies during COVID-19 pandemic
Nicolas Girard, L. Greillier, G. Zalcman, J. Cadranel +12 more
2020Respiratory medical research16 citations Open access
Semantic Scholar
Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP
F. Dubois, C. Bazille, J. Levallet, E. Maille +5 more
2022Targeted oncology15 citations Open access
Semantic Scholar
Immune checkpoint blockade for patients with lung cancer and idiopathic pulmonary fibrosis.
B. Duchemann, J. Pluvy, B. Crestani, G. Zalcman +1 more
2021European Journal of Cancer15 citations
Semantic Scholar
Apoptosis mapping in space and time of 3D tumor ecosystems reveals transmissibility of cytotoxic cancer death
I. Veith, A. Mencattini, V. Picant, M. Serra +10 more
2021PLoS Comput. Biol.15 citations Open access
Semantic Scholar
Influence of the SARS-CoV-2 outbreak on management and prognosis of new lung cancer cases, a retrospective multicentre real-life cohort study
S. Priou, G. Lamé, G. Zalcman, M. Wislez +8 more
2022European Journal of Cancer12 citations Open access
Semantic Scholar
Poor performance status patient with long-lasting major response to pembrolizumab in advanced non-small-cell lung cancer with coexisting POLE mutation and deficient mismatch repair pathway.
C. Vauchier, J. Pluvy, N. Theou-Anton, G. Soussi +4 more
2021Lung Cancer12 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

V. Gounant×13
Invite
V. Gounant — researcher profile on SciRah
B. Besse×11
Invite
B. Besse — researcher profile on SciRah
S. Brosseau×11
Invite
S. Brosseau — researcher profile on SciRah
C. Audigier-Valette×9
Invite
C. Audigier-Valette — researcher profile on SciRah

×8

Invite

A. Scherpereel — researcher profile on SciRah

J. Mazières×8

Invite

J. Mazières — researcher profile on SciRah

Invite

M. Wislez — researcher profile on SciRah

Invite

V. Westeel — researcher profile on SciRah

Invite

F. Barlesi — researcher profile on SciRah

L. Greillier×6

Invite

L. Greillier — researcher profile on SciRah

Invite

E. Pichon — researcher profile on SciRah

Invite

A. Cortot — researcher profile on SciRah